Respiratory

The details make the difference for a patient population that may be particularly burdened by the demands of respiratory clinical trials. We provide the necessary tools to address these details. For example, we ease travel burdens for whatever reason, through our ability to find patients near, but unknown to, research sites.

Virtual-first office visits, virtual pre-screening and telehealth also enable patients and their caregivers to reduce transport issues. Our on-site investigators bring experience conducting research in respiratory diseases and understand the patient journey, creating a superior patient experience. And having our sites located in the community—not at hospitals—brings more comfort and accessibility to patients potentially at risk of contracting severe illnesses. 

One of our innovations in recruiting respiratory disease patient populations is to screen across multiple indications at a portfolio level to realize efficiencies and subsequent cost reduction. Throughout the patient pre-screening process, innovative algorithms filter the patient data into the clinical trial with the best fit. Our virtual pre-screening process establishes background therapy and exacerbation history to potentially match patients with study eligibility criteria.